Alan Lewis is Director at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 8 open-market trades across 1 company since 2007, most recently 2019-06-04.
CIK 0001207604
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BMRN | 25,590 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2019-06-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMRN | SELL | 2018-08-28 | 2018-08-30 | $99.11 | $743K | -0.5% | -0.4% | -0.5% |
| BMRN | SELL | 2018-08-21 | 2018-08-22 | $100.09 | $420K | -5.4% | -3.4% | -9.7% |
| BMRN | SELL | 2014-12-04 | 2014-12-08 | $89.90 | $674K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2013-12-09 | 2013-12-11 | $69.91 | $1.6M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2013-02-27 | 2013-02-28 | $56.57 | $1.3M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2012-11-07 | 2012-11-09 | $46.80 | $702K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2012-08-06 | 2012-08-06 | $37.57 | $1.5M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2007-08-10 | 2007-08-14 | $20.08 | $402K | -18.2% | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.